MEDTE:PA:PA-BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF EUR Capitalisation (EUR)

ETF | Others |

Last Closing

USD 9.0503

Change

+0.07 (+0.73)%

Market Cap

N/A

Volume

307.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.06 (+0.14%)

USD 60.76B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.70 (+0.30%)

USD 13.44B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.48 (+0.12%)

USD 12.33B
WRD:PA HSBC MSCI World UCITS ETF

+0.14 (+0.39%)

USD 10.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+1.60 (+0.32%)

USD 8.88B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.24 (+0.93%)

USD 8.60B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.10 (+0.31%)

USD 7.71B
HHH:PA HSBC S&P 500 UCITS ETF

+0.19 (+0.32%)

USD 7.47B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.06 (+0.30%)

USD 6.81B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-0.01 (-0.01%)

USD 5.39B

ETFs Containing MEDTE:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.76% 90% A- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.76% 90% A- 81% B-
Trailing 12 Months  
Capital Gain 7.50% 33% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.50% 32% F 53% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.36% 26% F 41% F
Dividend Return 2.36% 26% F 38% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.25% 88% B+ 95% A
Risk Adjusted Return 55.39% 37% F 64% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.